Has Charles Ebert, MD received payments from drug or device companies?

Yes. Drug and device makers reported $56,983 in general payments to Charles Ebert, MD across 107 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Charles Ebert, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Charles Ebert, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Charles Ebert, MD

Otolaryngology · Chapel Hill, NCNPI 1114147022

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $47,120 of the $56,983 with a category attached, or 82.7%. Acclarent, Inc accounts for 74.9% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $16,994 and has fallen 96.9% since, to $523 in 2025. Among otolaryngology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$56,983in general payments, 2019–2025

Across 107 payments — averaging $532.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Acclarent, Inc$43K
Medtronic$6K
Medical Device Business Services, Inc.$4K
Integra Lifesciences Corporation$2K
3-d Matrix, Inc.$1K
Neurent Medical Limited$312
plus $426 from 5 others

What the payments were for

Consulting fees$47,12083%
Travel & lodging$2,5775%
Food & beverage$7,28613%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Acclarent, Inc	64	$42,658
Medtronic(2 entities)	9	$6,377
Medical Device Business Services, Inc.	5	$3,782
Integra Lifesciences Corporation	18	$2,308
3-d Matrix, Inc.	2	$1,121
Neurent Medical Limited	2	$312
Stryker	2	$174
GSK	1	$93
Aerin Medical Inc.	2	$64
Alk-abello, Inc	1	$62
Regeneron	1	$33

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ACCLARENT Balloon Inflation Device$31,509
ACCLARENT AERA EUSTACHIAN TUBE BALLOON DILATION SYSTEM$15,010
TruDi Nav Suction$11,988
StealthStation$6,239
TruDi$4,487
SpinPlus Navigation$4,246
TruDi Navigation System$3,160
Acclarent Aera$2,181
Inspira Air$1,886
TruDi Probe$1,478
RELIEVA SPINPLUS NAV$1,386
TruDi Nav Cable$1,178
NEUROMARK Device$312
NEUROMARK Radiofrequency Console$312
LATERA$156
ACCLARENT NAVWIRE Sinus Navigation Guidewire$125

How this compares

$56,983 in reported general payments places this provider in the 95th percentile of 362 otolaryngology providers in North Carolina.

See all otolaryngology providers in North Carolina →

Medicare billing

Part B allowed, 2024

$84,494

Medicare patients

170

Services billed

508

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Mometasone Furoate	33	$3,425
Fluticasone Propionate	153	$2,966
Ipratropium Bromide	86	$2,413
Mupirocin	33	$228
Azelastine Hcl	11	$223
Doxycycline Hyclate	18	$187
Chlorhexidine Gluconate	12	$89
Montelukast Sodium	19	$46
Omeprazole	13	$44

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Chapel Hill

Brent SeniorChapel Hill$91K
Harold PillsburyChapel Hill$42K
Nicholas ThompsonChapel Hill$24K
Anne SelleckChapel Hill$7K
Daniel AliceaChapel Hill$5K
Matthew MillerChapel Hill$5K
Trevor HackmanChapel Hill$4K
Justin MillerChapel Hill$4K
Carlton ZdanskiChapel Hill$4K
Doris LinChapel Hill$4K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →